Abstract
Purpose
To review a multicentric series of lateral-type posterior fossa ependymomas operated in the last ten years and to analyze the factors related to clinical evolution and tumor survival.
Methods
Descriptive, retrospective study. Active members of the Spanish Society of Pediatric Neurosurgery were invited to participate in this multicentric study. Clinical and radiological data were incorporated to an open database. The role of histologic grade, grade of resection, postoperative morbidities, and clinical follow-up was evaluated through bivariate associations (chi-square), Kaplan–Meier’s curves (log-rank test), and multivariate analysis (binary logistic regression).
Results
Fourteen centers entered the study, and 25 cases with a minimum follow-up of 6 months were included. There were 13 boys and 12 girls with a mean age close to 3 years. Mean tumor volume at diagnosis was over 60 cc. A complete resection was achieved in 8 patients and a near-total resection in 5 cases. Fifteen tumors were diagnosed as ependymoma grade 2 and ten as ependymoma grade 3. Major morbidity occurred postoperatively in 14 patients but was resolved in twelve within 6 months. There were six cases of death and 11 cases of tumor progression along the observation period. Mean follow-up was 44.8 months. Major morbidity was significantly associated with histologic grade but not with the degree of resection. Overall and progression-free survival were significantly associated with complete surgical resection. At the last follow-up, 16 patients carried a normal life, and three displayed a mild restriction according to Lansky’s scale.
Conclusions
Lateral-type posterior fossa ependymomas constitute a specific pathologic and clinical tumor subtype with bad prognosis. Gross total resection is the goal of surgical treatment, for it significantly improves prognosis with no additional morbidity. Neurological deficits associated to lower cranial nerve dysfunction are common, but most are transient. Deeper genetic characterization of these tumors may identify risk factors that guide new treatments and stratification of adjuvant therapies.
Similar content being viewed by others
Data Availability
Data are available through the secretary of the spanish pediatric of neurosurgery.
References
Baroni LV, Sundaresan L, Heled A, Coltin H, Pajtler KW, Lin T, Merchant TE, McLendon R, Faria C, Buntine M, White CL, Pfister SM, Gilbert MR, Armstrong TS, Bouffet E, Kumar S, Taylor MD, Aldape KD, Ellison DW, Gottardo NG, Kool M, Korshunov A, Hansford JR, Ramaswamy V (2021) Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q. Neuro Oncol 23:1360–1370. https://doi.org/10.1093/neuonc/noab034
Bertero L, Ricci AA, Tampieri C, Cassoni P, Modena P (2022) Ependymomas Pathologica 114:436–446. https://doi.org/10.32074/1591-951X-817
Delgado-López PD, Corrales-García EM, Alonso-García E, García-Leal R, González-Rodrigálvarez R, Araus-Galdós E, Martín-Alonso J (2019) Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues. Clin Transl Oncol 21:1450–1463
Dibs K, Prasad RN, Madan K, Liu K, Jiang W, Ghose J, Blakaj DM, Palmer JD, Kobalka P, Prevedello DM, Raval RR (2021) Cerebellopontine angle ependymoma presenting as isolated hearing loss in an elderly patient: a case report and literature review. Surg Neurol Int 12. https://doi.org/10.25259/SNI_781_2021
EVANS WA, (1942) An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatry 47:931. https://doi.org/10.1001/archneurpsyc.1942.02290060069004
House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngology-Head and Neck Surgery 93:146–147. https://doi.org/10.1177/019459988509300202
Ikezaki K, Matsushima T, Inoue T, Yokoyama N, Kaneko Y, Fukui M (1993) Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 32:38–44. https://doi.org/10.1227/00006123-199301000-00006
Indelicato DJ, Ioakeim-Ioannidou M, Bradley JA, Mailhot-Vega RB, Morris CG, Tarbell NJ, Yock T, MacDonald SM (2021) Proton therapy for pediatric ependymoma: mature results from a bicentric study. Int J Radiat Oncol Biol Phys 110:815–820. https://doi.org/10.1016/j.ijrobp.2021.01.027
Jünger ST, Timmermann B, Pietsch T (2021) Pediatric ependymoma: an overview of a complex disease. Childs Nerv Syst 37:2451–2463. https://doi.org/10.1007/s00381-021-05207-7
Kulkarni AV, Drake JM, Mallucci CL, Sgouros S, Roth J, Constantini S (2009) Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr 155:254-259.e1. https://doi.org/10.1016/j.jpeds.2009.02.048
Kulkarni AV, Piscion J, Shams I, Bouffet E (2013) Long-term quality of life in children treated for posterior fossa brain tumors. J Neurosurg Pediatr 12:235–240. https://doi.org/10.3171/2013.6.PEDS12535
Lan Z, Richard SA, Zhang Y (2019) Cerebellopontine angle ependymoma in a young adult : a case report. Medicine (United States) 98. https://doi.org/10.1097/MD.0000000000015019
Lansky LL, List MA, Lansky SB, Cohen ME, Sinks LF (1985) Toward the development of a play performance scale for children (PPSC). Cancer 56:1837–1840. https://doi.org/10.1002/1097-0142(19851001)56:7+%3c1837::aid-cncr2820561324%3e3.0.co;2-z
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, Von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Ma SC, De LC, Agazzi S, Jia W (2019) Clinical characteristics and prognostic factors of treatment in pediatric posterior cranial fossa ependymoma. Pediatr Neurosurg 54:98–107. https://doi.org/10.1159/000495809
Nagib MG, O’Fallon T (1996) Posterior fossa lateral ependymoma in childhood. Pediatr Neurosurg 24:299–305. https://doi.org/10.1159/000121059
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 21:v1–v100. https://doi.org/10.1093/neuonc/noz150
Pajtler KW, Mack SC, Ramaswamy V, Smith CA, Witt H, Smith A, Hansford JR, von Hoff K, Wright KD, Hwang E, Frappaz D, Kanemura Y, Massimino M, Faure-Conter C, Modena P, Tabori U, Warren KE, Holland EC, Ichimura K, Giangaspero F, Castel D, von Deimling A, Kool M, Dirks PB, Grundy RG, Foreman NK, Gajjar A, Korshunov A, Finlay J, Gilbertson RJ, Ellison DW, Aldape KD, Merchant TE, Bouffet E, Pfister SM, Taylor MD (2017) The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol 133:5–12. https://doi.org/10.1007/s00401-016-1643-0
Pajtler KW, Wen J, Sill M, Lin T, Orisme W, Tang B, Hübner JM, Ramaswamy V, Jia S, Dalton JD, Haupfear K, Rogers HA, Punchihewa C, Lee R, Easton J, Wu G, Ritzmann TA, Chapman R, Chavez L, Boop FA, Klimo P, Sabin ND, Ogg R, Mack SC, Freibaum BD, Kim HJ, Witt H, Jones DTW, Vo B, Gajjar A, Pounds S, Onar-Thomas A, Roussel MF, Zhang J, Taylor JP, Merchant TE, Grundy R, Tatevossian RG, Taylor MD, Pfister SM, Korshunov A, Kool M, Ellison DW (2018) Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathol 136:211–226. https://doi.org/10.1007/s00401-018-1877-0
Pajtler KW, Witt H, Sill M, Jones DTW, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743. https://doi.org/10.1016/j.ccell.2015.04.002
Panagopoulos D, Stranjalis G, Gavra M, Boviatsis E, Korfias S, Karydakis P, Themistocleous M (2023) The entity of cerebellar mutism syndrome: a narrative review centered on the etiology, diagnostics, prevention, and therapeutic options. Children 10
Peters S, Merta J, Schmidt L, Jazmati D, Kramer PH, Blase C, Tippelt S, Fleischhack G, Stock A, Bison B, Rutkowski S, Pietsch T, Kortmann RD, Timmermann B (2022) Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study. Neuro Oncol 24:1193–1202. https://doi.org/10.1093/neuonc/noab301
Ritzmann TA, Chapman RJ, Kilday JP, Thorp N, Modena P, Dineen RA, Macarthur D, Mallucci C, Jaspan T, Pajtler KW, Giagnacovo M, Jacques TS, Paine SML, Ellison DW, Bouffet E, Grundy RG (2022) SIOP ependymoma I: final results, long-term follow-up, and molecular analysis of the trial cohort - a BIOMECA consortium study. Neuro Oncol 24:936–948. https://doi.org/10.1093/neuonc/noac012
Rudà R, Bruno F, Pellerino A, Soffietti R (2022) Ependymoma: evaluation and management updates. Curr Oncol Rep 24:985–993
Rudà R, Reifenberger G, Frappaz D, Pfister SM, Laprie A, Santarius T, Roth P, Tonn JC, Soffietti R, Weller M, Moyal ECJ (2018) EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro Oncol 20:445–456. https://doi.org/10.1093/neuonc/nox166
Sabin ND, Hwang SN, Klimo P, Chambwe N, Tatevossian RG, Patni T, Li Y, Boop FA, Anderson E, Gajjar A, Merchant TE, Ellison DW (2021) Anatomic neuroimaging characteristics of posterior fossa type A ependymoma subgroups. Am J Neuroradiol 42:2245–2250. https://doi.org/10.3174/ajnr.A7322
Sabin ND, Merchant TE, Li X, Li Y, Klimo P, Boop FA, Ellison DW, Ogg RJ (2016) Quantitative imaging analysis of posterior fossa ependymoma location in children. Childs Nerv Syst 32:1441–1447. https://doi.org/10.1007/s00381-016-3092-4
Sanford RA, Kun LE, Heideman RL, Gajjar A (1997) Cerebellar pontine angle Ependymoma in infants. Pediatr Neurosurg 27:84–91. https://doi.org/10.1159/000121232
Sanford RA, Merchant TE, Zwienenberg-Lee M, Kun LE, Boop FA (2009) Advances in surgical techniques for resection of childhood cerebellopontine angle ependymomas are key to survival. Childs Nerv Syst 25:1229–1240. https://doi.org/10.1007/s00381-009-0886-7
Thomas S, Reynolds D, Morrall MCHJ, Limond J, Chevignard M, Calaminus G, Poggi G, Bennett E, Frappaz D, Slade D, Gautier J, McQuilton P, Massimino M, Grundy R (2019) The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: development and initial implementation of a cognitive test protocol for an international brain tumour trial. Eur J Paediatr Neurol 23:560–570. https://doi.org/10.1016/j.ejpn.2019.05.009
Tomita T, Grahovac G (2015) Cerebellopontine angle tumors in infants and children. Childs Nerv Syst 31:1739–1750. https://doi.org/10.1007/s00381-015-2747-x
U-King-Im JM, Taylor MD, Raybaud C, (2010) Posterior fossa ependymomas: new radiological classification with surgical correlation. Childs Nerv Syst 26:1765–1772. https://doi.org/10.1007/s00381-010-1251-6
Funding
No funding was obtained for this study.
Author information
Authors and Affiliations
Contributions
Pablo Miranda, Estela Plaza and Giovanni Pancucci contributed with 7 cases to the series; Antonio López-Guerrero and Diego López-Bermeo contributed each with 3 cases to the series; Teresa García Campos and Silvia Vázquez Sufuentes contributed with 2 cases to the series; Pablo M. Munárriz, Elena López-García, Alejandra Londoño-Quiroz, Cristina Ferreras-García, Mario García-Conde, Javier Saceda-Gutiérrez, Jorge Giménez-Pando and Sara Iglesias-Moroño contributed each with one case to the series. Pablo Miranda gathered the information and wrote the manuscript. All authors reviewed and approved the text. Pablo M. Munárriz made significant corrections to the manuscript text.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Miranda-Lloret, P., Plaza-Ramírez, E., López-Guerrero, A. et al. Lateral-type posterior fossa ependymomas in pediatric patients: a national collaborative study. Childs Nerv Syst 40, 407–416 (2024). https://doi.org/10.1007/s00381-023-06194-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-023-06194-7